Ex Vice President & Global Head of IP at Jazz Pharmaceuticals, having joined Jazz on the acquisition of GW Pharmaceuticals plc

At GW Chris was VP of IP, responsible for developing and implementing an IP strategy to protect GW’s entire portfolio of cannabis based products